摘要
目的对深圳市预防与控制梅毒母婴传播项目进行成本-效益分析,为政府决策提供参考依据。方法运用卫生经济学成本-效益理论,研究产前梅毒筛查实施结果。调查深圳市梅毒控制项目机构人员、临床医疗技术人员,同期随访部分梅毒患者家庭,掌握医患双方在项目防治过程中的成本,通过意愿支付法获取患者无形成本。结果梅毒控制项目总成本为27627552.36元,其中直接成本为1138451.79元,占4.12%,间接成本20448850.57元,占74.02%;无形成本6040250.00元,占21.86%;机构防治成本占总成本的73.84%,家庭成本占26.16%,医疗费部分占3.56%,社会成本则占96.44%。总效益为134898188.07元,其中直接效益为2608080.26元,间接效益为127412357.81元,同时避免了4877750.00元的无形成本。整个项目2003年的效益成本比为4.88∶1,其中直接效益成本比为2.29∶1,间接效益成本比为6.23∶1,无形效益成本比为0.81∶1。结论产前梅毒筛查是一个低投入、高产出的公益事业,不仅有巨大的经济效益,还有明显的社会效益。
Objective To analyze the cost-benefit of the project for syphilis prevention of mother-to-child transmission in Shenzhen and provide scientifice evidence for government policy making. Method Using the cost-benefit theory of socio-economic to investigate the result of antenatal syphilis screening, the staff of the project and the clinical specialists were interviewed, following - up was made to families with syphilis to find out the cost paid by the health care provider and patients and the intangible cost of the patients in the project. Result The total cost of the project was ￥27 627 552.36, which included the direct cost ￥1 138 451.79 （4.12%）, the indirect cost ￥20 448 850.57 （74.02%）, intangible cost ￥6 040 250.00（21.86 % ）. In other words it included agency cost （73.84 % ）, the family cost （26.16 % ）, the medical cost （3.56 % ） and the social cost （96.44 % ）. The total benefit was ￥ 134 898 188.07, which included the direct benefit ￥ 2 608 080.26, the indirect benefit ￥ 127 412 357.81, and the intangible benefit ￥ 4 877 750.00 as well. The benefit - cost ratio of the project in 2003 was 4.88：1, among which the direct benefit cost ratio（BCR） 2.29： 1, the indirect BCR was 6.23： 1, the intangible BCR 0.81 ： 1. Conclusion Antenatal syphilis screening is a lower - input and higher - output public welfare project, not only in economic but also in society.
出处
《中国公共卫生》
CAS
CSCD
北大核心
2007年第9期1062-1063,共2页
Chinese Journal of Public Health
基金
深圳市卫生科研基金重点课题(200404004)
深圳市重点医学专科基金
关键词
产前筛查
梅毒
成本-效益分析
antenatal screening
syphilis
cost - benefit analysis
